Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson’s diseaseA [11C]-raclopride PET study

被引：0
|
作者：
S. Thobois
V. Fraix
M. Savasta
N. Costes
P. Pollak
P. Mertens
A. Koudsie
D. Le Bars
A. L. Benabid
E. Broussolle
机构：
[1] Hôpital Neurologique Pierre Wertheimer,Dept. of Neurology D (Pr. G. Chazot) and INSERM U 534
[2] CHU,Dept. of Neurology and Neurosurgery
[3] Cyclotron Unit,CERMEP
[4] Hôpital Neurologique Pierre Wertheimer,Dept. of Neurosurgery A (Pr. M. Sindou)
[5] CHU,INSERM U 318
来源：
Journal of Neurology | 2003年 / 250卷
关键词：
Parkinson’s disease; subthalamic stimulation; dopamine; raclopride; PET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1219 / 1223
页数：4
相关论文
共 50 条
  • [41] PET imaging of striatal dopamine D2 receptors in nonhuman primates: Increases in availability produced by chronic raclopride treatment
    Czoty, PW
    Gage, HD
    Nader, MA
    SYNAPSE, 2005, 58 (04) : 215 - 219
  • [42] Increased striatal dopamine release in parkinsonian patients with pathological gambling: A 11C raclopride PET study
    Steeves, T. D. L.
    Miyasaki, J.
    Zurowski, M.
    Lang, A. E.
    Pellecchia, G.
    van Eimeren, T.
    Rusjan, R.
    Houle, S.
    Strafella, A. P.
    MOVEMENT DISORDERS, 2009, 24 : S252 - S252
  • [43] Is psychological stress in man associated with increased striatal dopamine levels?:: A [11C]raclopride PET study
    Montgomery, AJ
    Mehta, MA
    Grasby, PM
    SYNAPSE, 2006, 60 (02) : 124 - 131
  • [44] Effect of sensory stimulus on striatal dopamine release in humans and cats:: a [11C]raclopride PET study
    Thobois, S
    Hassoun, W
    Ginovart, N
    Garcia-Larrea, L
    Le Cavorsin, M
    Guillouet, S
    Bonnefoi, F
    Costes, N
    Lavenne, F
    Broussolle, E
    Leviel, V
    NEUROSCIENCE LETTERS, 2004, 368 (01) : 46 - 51
  • [45] Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
    Steeves, T. D. L.
    Miyasaki, J.
    Zurowski, M.
    Lang, A. E.
    Pellecchia, G.
    Van Eimeren, T.
    Rusjan, P.
    Houle, S.
    Strafella, A. P.
    BRAIN, 2009, 132 : 1376 - 1385
  • [46] No "ceiling effect" observed with the exogenous dopamine agonist apomorphine -: A PET study with the dopamine D2 receptor agonist radioligand [11C]MNPA and antagonist radioligand [11C]Raclopride
    Finnema, S. J.
    Bang-Andersen, B.
    Farde, L.
    Gulyas, B.
    Wikstrom, H. V.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S211 - S211
  • [47] Comparison of manual and automated methods for measuring striatal D2 receptor binding in primary dystonia: a PET study with [11C]Raclopride
    Peng, S.
    Ma, Y.
    Carbon, M.
    Bressman, S.
    Dhawan, V.
    Eidelberg, D.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2009, 29 : S332 - S332
  • [48] (11C)-N-methylspiperone PET detects different levels of dopamine D2 receptor occupancy of an atypical neuroleptic than (11C)-raclopride PET
    Hagberg, G
    Gefvert, O
    Bergström, M
    Wieselgren, IM
    Lindström, L
    Wiesel, FA
    Långström, B
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 165 - 166
  • [49] Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys:: PET studies with [11C]raclopride
    Doudet, DJ
    Jivan, S
    Ruth, TJ
    Holden, JE
    SYNAPSE, 2002, 44 (03) : 198 - 202
  • [50] Occupancy of Dopamine D2 and D3 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans
    Le Foll, Bernard
    Payer, Doris
    Di Ciano, Patricia
    Guranda, Mihail
    Nakajima, Shinichiro
    Tong, Junchao
    Mansouri, Esmaeil
    Wilson, Alan
    Houle, Sylvain
    Meyer, Jeff
    Graff, Ariel
    Boileau, Isabelle
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 94S - 94S
12345